Interest of the Peak of Reticulocytes in Chronic Hemodialysis Patients Treated by Mircera
Phase of Trial: Phase III
Latest Information Update: 23 Oct 2017
At a glance
- Drugs Methoxy polyethylene glycol-epoetin beta (Primary)
- Indications Anaemia
- Focus Therapeutic Use
- Acronyms RETICERA
- 22 Jun 2017 Planned End Date changed from 1 Jul 2018 to 22 Dec 2019.
- 22 Jun 2017 Planned primary completion date changed from 1 Jan 2018 to 22 Dec 2018.
- 19 Jul 2016 New trial record